The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BASECAMP-1: An approach to improve patient screening efficiency and to provide large datasets for precision medicine clinical trials.
 
Kristen Spencer
Honoraria - Amplity Health; Bio Ascend Oncology; Dava Oncology
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; Caris Life Sciences; Exelixis; Genentech/Roche
Speakers' Bureau - American Cancer Society
Research Funding - BMS Foundation
Travel, Accommodations, Expenses - ASCO; Cholangiocarcinoma Foundation
 
Matthew Ulrickson
Consulting or Advisory Role - ADC Therapeutics; Autolus; Bristol-Myers Squibb/Celgene/Juno; Genentech; Kura Oncology; Stemline Therapeutics
Research Funding - Immunogen; Kite, a Gilead company
Travel, Accommodations, Expenses - Miltenyi Biotec
 
Patrick Grierson
Employment - Walgreens (I)
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Patents, Royalties, Other Intellectual Property - Compositions and Methods for the Treatment of Pancreatic Cancer
 
Sandip Patel
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Certis Oncology Solutions; Compugen; Illumina; Iovance Biotherapeutics (Inst); Lilly; Lilly; Merck; Nektar; Novartis; Pfizer; Roche/Genentech; Tempus
Speakers' Bureau - Boehringer Ingelheim; Merck
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Fate Therapeutics (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Rubius Therapeutics; Takeda (Inst); Takeda (Inst)
 
Jennifer Specht
Honoraria - BioNTech SE; Daiichi Sankyo; SCRIPPS Research Institute; Sensei Biotherapeutics
Consulting or Advisory Role - BioNTech SE; Boehringer Ingelheim; Daiichi Sankyo; GE Healthcare; Lyell Immunopharma Inc
Research Funding - A2 Biotherapeutics (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Biocity (Inst); Carisma Therapeutics (Inst); Celcuity (Inst); Genentech (Inst); Lyell Immunopharma (Inst); Merck (Inst); OnKure (Inst); Pfizer (Inst); Seagen (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - UW CoMotion - Patent Royalty for ROR1 CAR (Inst)
Travel, Accommodations, Expenses - A2 Biotherapeutics; Dava Oncology; GE Healthcare; GlaxoSmithKline; iwCAR-T; Nektar
 
Jong Chul Park
Honoraria - Coherus Biosciences; MitoImmune; Selecxine
Consulting or Advisory Role - Hanall Biopharma; Hanmi Pharma
Research Funding - A2 Bio (Inst); A2 Biotherapeutics (Inst); Alentis Therapeutics (Inst); ALX Oncology (Inst); Ankyra Therapeutics (Inst); CUE Biopharma (Inst); InhibRx (Inst); ISA Pharmaceuticals (Inst)
 
Hemant Murthy
Consulting or Advisory Role - Acceleron Pharma; Autolus; Bavarian Nordic; Bristol Myers Squibb Foundation; CRISPR Therapeutics; Jazz Pharmaceuticals; Senti Biosciences; SOBI
Research Funding - Abbvie (Inst); Amgen (Inst); crispr therapeutics (Inst)
 
Diane Simeone
Leadership - Immodulon; Immunovia
Stock and Other Ownership Interests - Longevity Life Advisors
Honoraria - Pfizer
Consulting or Advisory Role - FibroGen
Research Funding - Biological Dynamics; Clearnote Health; Immunovia; Micronoma
Patents, Royalties, Other Intellectual Property - small royalties for my patent on pancreatic cancer stem cells also I receive an annual royalty for a textbook I edited Greenfields Textbook of Surgery
 
Maria Pia Morelli
No Relationships to Disclose
 
David Maloney
Stock and Other Ownership Interests - A2 Biotherapeutics
Honoraria - A2 Biotherapeutics; Bristol-Myers Squibb/Celgene; Genentech/Roche; Gilead Sciences; Kite, a Gilead company; Lyell Immunopharma; Novartis; Umoja Biopharma
Consulting or Advisory Role - A2 Biotherapeutics; Celgene/Bristol-Myers Squibb; Genentech; NAVAN Technologies
Research Funding - Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on 4 provisional patents.
 
Marcela Maus
Leadership - 2seventy bio
Stock and Other Ownership Interests - 2seventy bio; A2Bio; Affyimumune; BendBio; CARGO Therapeutics; GBM newco; Model T Bio; NexImmune; Oncternal Therapeutics
Consulting or Advisory Role - Adaptimmune; AffyImmune Therapeutics; Agenus; arcellx; Astellas Pharma; AstraZeneca; Atara Biotherapeutics; Bayer; BMS; Cabaletta Bio; Cabaletta Bio; Chugai Pharma; crispr therapeutics; GlaxoSmithKline; In8Bio; In8bio; Intellia Therapeutics; Kite, a Gilead company; MicroMedicine; Novartis; Oncternal Therapeutics; Sanofi; TCR2 Therapeutics; Tmunity Therapeutics, Inc.; Torque; windmil
Research Funding - Kite, a Gilead company (Inst); Moderna Therapeutics (Inst); Servier (Inst); Sobi (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on patents held by Massachusetts General Hospital/Partners Health care; all related to CAR T cells and/or gene therapy; Inventor on patents held by U. Pennsylvania with and without Novartis
 
Wen-Kai Weng
No Relationships to Disclose
 
Cathy Eng
Consulting or Advisory Role - Abbvie; Agenus; Amgen (I); EMD Serono; Merck Serono; Merus; Pfizer; Revolution Medicines; Taiho Oncology (I); Takeda
Research Funding - Gritstone Bio (Inst); Hutchison MediPharma (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Sumitomo Dainippon Pharma Oncology (Inst)
Travel, Accommodations, Expenses - Takeda
 
Kai He
Consulting or Advisory Role - AstraZeneca; BioNTech SE; Bristol-Myers Squibb; Iovance Biotherapeutics; Lyell Immunopharma; Mirati Therapeutics; Obsidian Therapeutics; oncoc4; Perthera; Pfizer
Research Funding - Abbvie (Inst); Adaptimmune (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Iovance Biotherapeutics (Inst); Mirati Therapeutics (Inst); Oncoc4 (Inst)
 
Brittany Waschke
Employment - A2 Biotherapeutics; Atara Biotherapeutics; Coherus BioSciences (I)
Stock and Other Ownership Interests - A2 Biotherapeutics; Coherus BioSciences (I)
Travel, Accommodations, Expenses - A2 Biotherapeutics; Coherus BioSciences (I)
 
Eric Ng
Employment - A2 Biotherapeutics; Amgen
Stock and Other Ownership Interests - A2 Biotherapeutics; Amgen
Travel, Accommodations, Expenses - A2 Biotherapeutics; Amgen
 
Jessica Tebbets
Employment - A2 Biotherapeutics
Stock and Other Ownership Interests - A2 Biotherapeutics
 
Kedar Kirtane
Leadership - MyCareGorithm
Stock and Other Ownership Interests - Agenus; Oncternal Therapeutics; Veru
Consulting or Advisory Role - MyCareGorithm
Research Funding - Turnstone Bio
Travel, Accommodations, Expenses - A2Bio
 
Joel Hecht
Stock and Other Ownership Interests - Actym Therapeutics; Rafael Pharmaceuticals; Trumvira
Consulting or Advisory Role - Agenus; Astellas Pharma; BeiGene; Bristol-Myers Squibb/Medarex; Galvanize Therapeutics; MBQ Pharma; Revolution Medicines; Taiho Pharmaceutical; Xilio Therapeutics
Research Funding - A2 Biotherapeutics (Inst); Affini-T Therapeutics (Inst); Agenus (Inst); Amgen (Inst); Bold Therapeutics (Inst); Camurus (Inst); Cardiff Oncology (Inst); CG Pharmaceuticals (Inst); Crinetics Pharmaceuticals (Inst); Exelixis (Inst); Gilead Sciences (Inst); Gritstone Bio (Inst); Janssen Oncology (Inst); Lyell Immunopharma (Inst); Merck (Inst); Mirati Therapeutics (Inst); Neogene Therapeutics (Inst); NGM Biopharmaceuticals (Inst); Regeneron (Inst); Revolution Medicines (Inst); Seagen (Inst); Tizona Therapeutics, Inc. (Inst); Tizona Therapeutics, Inc. (Inst); Xilio Therapeutics (Inst)
 
Julian Molina
No Relationships to Disclose